We are live on ! Find out more
ACB

Aristotle Capital Boston Portfolio holdings

AUM $1.61B
1-Year Est. Return 19.82%
This Fund
S&P 500
This Quarter Est. Return
+9.38%
1 Year Est. Return
+19.82%
3 Year Est. Return
+51.6%
5 Year Est. Return
+74.11%
10 Year Est. Return
+400.29%
AUM
$1.26B
AUM Growth
-$866M
Cap. Flow
-$1,000M
Cap. Flow %
-79.26%
Top 10 Hldgs %
18.19%
Holding
127
New
3
Increased
7
Reduced
113
Closed
4

Sector Composition

Rank Sector Weight
1 Industrials 23.15%
2 Financials 14.74%
3 Technology 13.29%
4 Healthcare 12.72%
5 Consumer Discretionary 7.87%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AZPN
26
DELISTED
ASPEN TECHNOLOGY INC
AZPN
$15.5M 1.23%
166,904
-129,874
-44% -$12M
HASI icon
27
Hannon Armstrong Sustainable Infrastructure Capital
HASI
$4.81B
$15.1M 1.19%
762,172
-5,286
-0.7% -$100K
MATW icon
28
Matthews International
MATW
$887M
$14.9M 1.18%
254,140
-175,071
-41% -$9.34M
CMCO icon
29
Columbus McKinnon
CMCO
$422M
$14.7M 1.17%
340,078
-15,440
-4% -$598K
BDC icon
30
Belden
BDC
$3.97B
$14.7M 1.16%
239,797
-178,759
-43% -$11M
SP
31
DELISTED
SP Plus Corporation
SP
$14.3M 1.13%
384,338
-17,419
-4% -$639K
MODV
32
DELISTED
ModivCare
MODV
$14.1M 1.12%
179,562
-30,202
-14% -$2.27M
CWST icon
33
Casella Waste Systems
CWST
$5.76B
$14M 1.11%
548,533
-93,621
-15% -$2.31M
AEL
34
DELISTED
American Equity Investment Life Holding Company
AEL
$14M 1.11%
388,264
-293,842
-43% -$9.48M
CRL icon
35
Charles River Laboratories
CRL
$11.3B
$13.5M 1.07%
120,399
-125,460
-51% -$13.6M
NUS icon
36
Nu Skin
NUS
$257M
$13.5M 1.07%
172,743
-106,341
-38% -$8.24M
IWM icon
37
iShares Russell 2000 ETF
IWM
$79.1B
$13.4M 1.06%
81,977
-57,081
-41% -$9.13M
TCF
38
DELISTED
TCF Financial Corporation Common Stock
TCF
$13.3M 1.06%
239,694
-219,251
-48% -$12.4M
KRA
39
DELISTED
Kraton Corporation
KRA
$13.3M 1.05%
288,371
-207,642
-42% -$10.1M
CUBI icon
40
Customers Bancorp
CUBI
$2.66B
$13.2M 1.04%
463,710
-20,402
-4% -$609K
ACHC icon
41
Acadia Healthcare
ACHC
$2.55B
$13.1M 1.04%
320,627
-214,360
-40% -$8.64M
PBH icon
42
Prestige Consumer Healthcare
PBH
$2.47B
$13M 1.03%
337,663
-173,515
-34% -$5.85M
NOVT icon
43
Novanta
NOVT
$4.91B
$12.9M 1.03%
207,632
-9,243
-4% -$565K
MD icon
44
Pediatrix Medical
MD
$2.2B
$12.9M 1.02%
298,268
-218,310
-42% -$10.5M
CHEF icon
45
Chefs' Warehouse
CHEF
$4.31B
$12.6M 1%
442,746
-18,420
-4% -$483K
HMSY
46
DELISTED
HMS Holdings Corp.
HMSY
$12.5M 0.99%
578,866
-291,277
-33% -$5.89M
AIN icon
47
Albany International
AIN
$2.09B
$12.5M 0.99%
207,305
-181,250
-47% -$11.2M
FFBC icon
48
First Financial Bancorp
FFBC
$3.55B
$12.4M 0.98%
404,074
-376,951
-48% -$11.8M
WAB icon
49
Wabtec
WAB
$49.3B
$12.1M 0.96%
122,803
-5,463
-4% -$508K
INWK
50
DELISTED
InnerWorkings, Inc.
INWK
$12.1M 0.96%
1,389,642
-63,078
-4% -$582K

Similar funds

Aristotle Capital Boston's Q2 2018 Portfolio in Review

As of Q2 2018, Aristotle Capital Boston held 127 positions worth $1.26B, down 41% from $2.13B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Aristotle Capital Boston withdrew a net $1,000M in Q2 2018, closing 4 positions and reducing 113 holdings. Its most notable exit was Microsemi Corp, an estimated $40.1M position sold in full.

By sector, the portfolio is most concentrated in Industrials at 23% of assets, up from 20% a quarter earlier, followed by Financials and Technology.

Against the trend, Aristotle Capital Boston opened a new position in U.S. Xpress Enterprises, Inc. Class A Common Stock worth $4.81M.

  • Aristotle Capital Boston's largest Q2 2018 buy was U.S. Xpress Enterprises, Inc. Class A Common Stock: 317,801 shares worth $4.81M.
  • Aristotle Capital Boston added most to ATN International in Q2 2018, an estimated $2.64M increase.
  • Aristotle Capital Boston's biggest Q2 2018 reduction was Everforth Inc, cutting an estimated $31.9M.
  • Aristotle Capital Boston fully exited Microsemi Corp in Q2 2018, selling an estimated $40.1M.
  • Aristotle Capital Boston's ten largest holdings make up 18% of its $1.26B portfolio in Q2 2018.
  • Aristotle Capital Boston opened 3 new positions and closed 4 in Q2 2018.
  • Aristotle Capital Boston's portfolio value fell 41% quarter-over-quarter to $1.26B.

Based on Aristotle Capital Boston's 13F filing for Q2 2018, filed 13 Aug 2018.